Halozyme Therapeutics Inc (HALO)
Debt-to-assets ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 2,063,480 | 1,733,270 | 1,841,510 | 1,104,430 | 579,924 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $2,063,480K
= 0.00
The debt-to-assets ratio for Halozyme Therapeutics Inc has consistently remained at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not used any debt financing to acquire assets during this period. A debt-to-assets ratio of 0.00 suggests that the company's assets are entirely financed by equity, which can be a positive sign for investors and lenders as it signifies lower financial risk and a strong financial position. This also implies that the company may have a conservative approach towards leveraging its operations and growth, focusing on organic expansion or alternative sources of capital.
Peer comparison
Dec 31, 2024